Eun Young Choi

Eun Young Choi

Auto-generated profile, based on publicly available information

Eun Young Choi

Department of Biomedical Sciences, University of Ulsan College of Medicine, Seoul 05505, Korea

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2012 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MEMehmet A Eskan
Mehmet A Eskan
RJRavi Jotwani
Ravi Jotwani
TAToshiharu Abe
Toshiharu Abe
JCJindřich Chmelař
Jindřich Chmelař
JLJong-Hyung Lim
Jong-Hyung Lim
GHGeorge Hajishengallis
George Hajishengallis

1 February 2007 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
VOValeria V. Orlova
Valeria V. Orlova
ECEun Young Choi
Eun Young Choi
CXChangping Xie
Changping Xie
ECEmmanouil Chavakis
Emmanouil Chavakis
ABAngelika Bierhaus
Angelika Bierhaus
TCTriantafyllos Chavakis
Triantafyllos Chavakis
High‐mobility group box 1 (HMGB1) is released extracellularly upon cell necrosis acting as a mediator in tissue injury and inflammation. However, the molecular mechanisms for the proinflammatory effect of HMGB1 are poorly understood. Here, we define a novel function of HMGB1 in promoting Mac‐1‐dependent neutrophil recruitment. HMGB1 administration induced rapid neutrophil recruitment in vivo . HMGB1‐mediated recruitment was prevented in mice deficient in the β2‐integrin Mac‐1 but not in those deficient in LFA‐1. As observed by bone marrow chimera experiments, Mac‐1‐dependent neutrophil recruitment induced by HMGB1 required the presence of receptor for advanced glycation end products (RAGE) on neutrophils but not on endothelial cells. In vitro , HMGB1 enhanced the interaction between Mac‐1 and RAGE. Consistently, HMGB1 activated Mac‐1 as well as Mac‐1‐mediated adhesive and migratory functions of neutrophils in a RAGE‐dependent manner. Moreover, HMGB1‐induced activation of nuclear factor‐κB in neutrophils required both Mac‐1 and RAGE. Together, a novel HMGB1‐dependent pathway for inflammatory cell recruitment and activation that requires the functional interplay between Mac‐1 and RAGE is described here.

14 November 2008 in Science
Verified
Journal Article
Closed access
PDF file
ECEun Young Choi
Eun Young Choi
ECEmmanouil Chavakis
Emmanouil Chavakis
MCMarcus A. Czabanka
Marcus A. Czabanka
HLHarald F. Langer
Harald F. Langer
LFLine Fraemohs
Line Fraemohs
TCTriantafyllos Chavakis
Triantafyllos Chavakis
Leukocyte recruitment to sites of infection or inflammation requires multiple adhesive events. Although numerous players promoting leukocyte-endothelial interactions have been characterized, functionally important endogenous inhibitors of leukocyte adhesion have not been identified. Here we describe the endothelially derived secreted molecule Del-1 (developmental endothelial locus–1) as an anti-adhesive factor that interferes with the integrin LFA-1–dependent leukocyte-endothelial adhesion. Endothelial Del-1 deficiency increased LFA-1–dependent leukocyte adhesion in vitro and in vivo. Del-1 –/– mice displayed significantly higher neutrophil accumulation in lipopolysaccharide-induced lung inflammation in vivo, which was reversed in Del-1/LFA-1 double-deficient mice. Thus, Del-1 is an endogenous inhibitor of inflammatory cell recruitment and could provide a basis for targeting leukocyte-endothelial interactions in disease.

1 August 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
USUlrich J. H. Sachs
Ulrich J. H. Sachs
CACornelia L. Andrei-Selmer
Cornelia L. Andrei-Selmer
AMAmudhan Maniar
Amudhan Maniar
TWTimo Weiss
Timo Weiss
CPCathy Paddock
Cathy Paddock
SSSentot Santoso
Sentot Santoso
Human neutrophil-specific CD177 (NB1 and PRV-1) has been reported to be up-regulated in a number of inflammatory settings, including bacterial infection and granulocyte-colony-stimulating factor application. Little is known about its function. By flow cytometry and immunoprecipitation studies, we identified platelet endothelial cell adhesion molecule-1 (PECAM-1) as a binding partner of CD177. Real-time protein-protein analysis using surface plasmon resonance confirmed a cation-dependent, specific interaction between CD177 and the heterophilic domains of PECAM-1. Monoclonal antibodies against CD177 and against PECAM-1 domain 6 inhibited adhesion of U937 cells stably expressing CD177 to immobilized PECAM-1. Transendothelial migration of human neutrophils was also inhibited by these antibodies. Our findings provide direct evidence that neutrophil-specific CD177 is a heterophilic binding partner of PECAM-1. This interaction may constitute a new pathway that participates in neutrophil transmigration.

27 April 2012 in Circulation Research
Verified
Journal Article
Closed access
PDF file
HLHarald Langer
Harald Langer
ECEun Young Choi
Eun Young Choi
HZHong Zhou
Hong Zhou
RSRebecca Schleicher
Rebecca Schleicher
KCKyoung-Jin Chung
Kyoung-Jin Chung
TCTriantafyllos Chavakis
Triantafyllos Chavakis
Rationale:: Multiple sclerosis (MS) and its mouse model, experimental autoimmune encephalomyelitis (EAE), are inflammatory disorders of the central nervous system (CNS). The function of platelets in inflammatory and autoimmune pathologies is thus far poorly defined. Objective:: We addressed the role of platelets in mediating CNS inflammation in EAE. Methods and Results:: We found that platelets were present in human MS lesions as well as in the CNS of mice subjected to EAE but not in the CNS from control nondiseased mice. Platelet depletion at the effector-inflammatory phase of EAE in mice resulted in significantly ameliorated disease development and progression. EAE suppression on platelet depletion was associated with reduced recruitment of leukocytes to the inflamed CNS, as assessed by intravital microscopy, and with a blunted inflammatory response. The platelet-specific receptor glycoprotein Ibα (GPIbα) promotes both platelet adhesion and inflammatory actions of platelets and targeting of GPIbα attenuated EAE in mice. Moreover, targeting another platelet adhesion receptor, glycoprotein IIb/IIIa (GPIIb/IIIa), also reduced EAE severity in mice. Conclusions:: Platelets contribute to the pathogenesis of EAE by promoting CNS inflammation. Targeting platelets may therefore represent an important new therapeutic approach for MS treatment.

25 November 2010 in Blood
Verified
Journal Article
Open access
PDF file
HLHarald F. Langer
Harald F. Langer
KCKyoung-Jin Chung
Kyoung-Jin Chung
VOValeria V. Orlova
Valeria V. Orlova
ECEun Young Choi
Eun Young Choi
SKSunil Kaul
Sunil Kaul
TCTriantafyllos Chavakis
Triantafyllos Chavakis
Beyond its role in immunity, complement mediates a wide range of functions in the context of morphogenetic or tissue remodeling processes. Angiogenesis is crucial during tissue remodeling in multiple pathologies; however, the knowledge about the regulation of neovascularization by the complement components is scarce. Here we studied the involvement of complement in pathological angiogenesis. Strikingly, we found that mice deficient in the central complement component C3 displayed increased neovascularization in the model of retinopathy of prematurity (ROP) and in the in vivo Matrigel plug assay. In addition, antibody-mediated blockade of C5, treatment with C5aR antagonist, or C5aR deficiency in mice resulted in enhanced pathological retina angiogenesis. While complement did not directly affect angiogenesis-related endothelial cell functions, we found that macrophages mediated the antiangiogenic activity of complement. In particular, C5a-stimulated macrophages were polarized toward an angiogenesis-inhibitory phenotype, including the up-regulated secretion of the antiangiogenic soluble vascular endothelial growth factor receptor-1. Consistently, macrophage depletion in vivo reversed the increased neovascularization associated with C3- or C5aR deficiency. Taken together, complement and in particular the C5a-C5aR axes are potent inhibitors of angiogenesis.